Final answer:
Allosync DBM becomes more viscous at body temperature due to a carrier in the product that has thermosensitive properties. These carriers might include substances such as gelatin, glycerol, or hyaluronic acid, which aid in the material's application and stability.
Step-by-step explanation:
The Allosync DBM (Demineralized Bone Matrix) product is designed to become more viscous at body temperature. This property is essential in medical applications, particularly in orthopedic and spinal surgeries, where the DBM is used as a graft material. The carrier within Allosync, while not specified in the available information, typically consists of substances that undergo a phase transition or have thermosensitive properties which would cause an increase in viscosity at elevated temperatures such as the normal human body temperature.
For example, carriers in some DBM products can include materials such as gelatin, glycerol or hyaluronic acid, which are known to become more viscous at body temperature, facilitating their application and stability in the body during the healing process. The Allosync DBM is then able to provide a scaffold that supports bone growth and healing due to this thermoviscous feature.